Navigation Links
Posit Science(R) Corporation Announces the Release of InSight(TM) 1.1
Date:11/13/2008

Brain fitness program that improves driving now includes personalized

progress tracking

SAN FRANCISCO, Nov. 13 /PRNewswire/ -- Effective immediately, Posit Science Corporation will begin shipping InSight Version 1.1 for Windows. This new release includes enhancements that enable users to closely track and understand the brain fitness gains they are making as they progress through the software, providing a highly personalized user experience.

InSight is a brain fitness software program that improves visual processing and memory. People's ability to take in and respond to what they see depends as much on the brain as the eyes. InSight speeds up and sharpens the brain's visual system so that people see more and react faster to what's around them, such as a child wandering into the street. Using InSight positively impacts essential daily activities, especially driving. In fact, InSight has been proven to cut the risk of auto accidents in half by dramatically improving driving performance.

InSight 1.1 allows users to track every step of their training experience through customized progress update messages. It also informs users about how the cognitive improvements they are making in the exercises will be expressed in everyday activities, such as grocery shopping, playing sports and driving.

Sixty-three year old Linda Stack is certain using InSight makes her a safer driver. "Lately, my peripheral vision was not what it should be," she said. "It was noticeable, especially when I was driving. I didn't want my wake up call to come when I had an accident so I was excited to try InSight. It has given me confidence and makes me feel that I can drive safely."

This new version of InSight also gives program participants flexibility to use InSight on more than one computer. Users can download their exercise data to pick up their training where they left off.

"We heard across the board from customers who wanted more information about tracking their progress," said Eric Mann, Posit Science Vice President of Marketing, "and we listened. Our goal at Posit Science is to provide state of the art, consumer driven products that make a difference in people's lives."

Existing InSight customers can upgrade to version 1.1 for $29.95 plus shipping and handling. The upgrade program will be available January 15, 2009.

The next release of InSight will be for Mac users and is currently in beta testing.

The standard retail price for InSight is $395 for a single user and $495 for two users. Purchasers can qualify for a $50 rebate per user by completing the recommended training schedule.

About Posit Science:

Posit Science is the leading provider of clinically validated brain fitness products and services. The company works with more than 50 scientists from prestigious universities to design and test its computer-based programs. More than 30 published studies show that the company's patented technologies significantly increase processing speed, improve memory, and enhance the quality of everyday life. Posit Science has received numerous grants and awards from groups such as the National Institutes of Health (NIH), the American Society for Aging (ASA), and CNBC. For more information, visit http://www.PositScience.com or call 1-866-599-6463.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
4. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
5. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
8. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
9. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
10. Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
11. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... and GERMANTOWN, Maryland , ... Frankfurt Prime Standard: QIA) today announced the introduction of ... gene expression profiling, expanding QIAGEN,s portfolio of Sample to ... researchers to select from over 20,000 human genes and ... between genes, cellular phenotypes and disease processes. --> ...
(Date:2/11/2016)... 2016  Dovetail Genomics™ LLC today announced that it ... a planned metagenomic genome assembly service. Richard Green ... assembly method in a talk on Friday, February 12 ... conference in Orlando, Fla. ... is difficult. Using its proprietary Chicago ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... of its new stem cell treatment clinic in Quito, Ecuador. The new facility ... and trauma applications to patients from around the world. , The new ...
Breaking Biology Technology:
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/25/2016)... 2016  Glencoe Software, the world-leading supplier of image ... will provide the data management solution OMERO Plus for ... Photo - ... Phenotypic analysis measures the characteristics and behavior ... between states such as health and disease, the presence ...
Breaking Biology News(10 mins):